The University Hospital of Liverpool Group are UHLG dedicated to advancing patient care through cutting-edge research in anaesthesia.
Our ongoing clinical trials explore new treatments and techniques to improve safety, recovery, and outcomes for patients undergoing surgery. Explore our current studies and learn how we’re working to shape the future of anaesthetic care
The CRASH-4 trial will test if giving a shot of tranexamic acid into the muscle right after a mild head injury in older adults can stop bleeding in the brain before it even starts and help recovery.
The main goal of the trial is to find out the best time for people to start or restart a blood-thinning medicine called a DOAC after a head injury.
he study will also look at how well people recover, their overall quality of life, how many people pass away, the costs of treatment, and what people and their caregivers think about starting or restarting the medicine.
To find out if using a special breathing tube, a supraglottic airway, works better than the usual tube (tracheal intubation) for adults who have a cardiac arrest in the hospital.
This study will see if adding a pain relief method called RSCs to regular patient-controlled pain medicine helps people feel less pain, have fewer side effects, and be more satisfied after emergency stomach surgery.
A large study at multiple sites, testing several treatments openly, with a built-in initial trial and an ongoing cost analysis.
This study will test a new decision support tool to help high-risk patients make more informed choices about major surgery. Patients at 40 hospitals will be part of the trial, which compares usual care to the new tool to see if it improves shared decision-making and long-term outcomes.
